Gildon Beall

2.7k total citations · 1 hit paper
41 papers, 2.1k citations indexed

About

Gildon Beall is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Gildon Beall has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 13 papers in Epidemiology and 10 papers in Virology. Recurrent topics in Gildon Beall's work include HIV/AIDS Research and Interventions (12 papers), HIV Research and Treatment (10 papers) and HIV/AIDS drug development and treatment (9 papers). Gildon Beall is often cited by papers focused on HIV/AIDS Research and Interventions (12 papers), HIV Research and Treatment (10 papers) and HIV/AIDS drug development and treatment (9 papers). Gildon Beall collaborates with scholars based in United States, Sweden and Canada. Gildon Beall's co-authors include Peter Ruane, Martin King, José Ramón Arribas, David W. Johnson, Scott Brun, Eugene Sun, Richard Lalonde, Sharon Walmsley, Margaret Johnson and Anthony J. Japour and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Clinical Infectious Diseases.

In The Last Decade

Gildon Beall

41 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection

2002 518 citations Sharon Walmsley, Barry Bernstein et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gildon Beall United States	21	1.3k	885	479	386	275	41	2.1k
Laura Waters United Kingdom	25	1.6k 1.3×	936 1.1×	472 1.0×	798 2.1×	103 0.4×	96	2.2k
Eva Wolf Germany	24	867 0.7×	480 0.5×	803 1.7×	297 0.8×	165 0.6×	108	2.3k
Michael P. Dubé United States	33	1.9k 1.5×	1.2k 1.3×	926 1.9×	1.5k 3.8×	228 0.8×	96	3.2k
Michael F. Para United States	21	1.3k 1.0×	1.0k 1.1×	531 1.1×	411 1.1×	39 0.1×	55	2.0k
Joaquín Portilla Spain	23	1.4k 1.1×	940 1.1×	753 1.6×	564 1.5×	93 0.3×	160	2.3k
Tiziana Quirino Italy	22	841 0.7×	493 0.6×	331 0.7×	557 1.4×	116 0.4×	60	1.5k
Fiona Mulcahy Ireland	23	1.1k 0.9×	679 0.8×	428 0.9×	287 0.7×	45 0.2×	48	2.1k
Stephen Raffanti United States	25	1.2k 0.9×	711 0.8×	508 1.1×	673 1.7×	51 0.2×	58	1.9k
Ighovwerha Ofotokun United States	29	929 0.7×	550 0.6×	336 0.7×	991 2.6×	63 0.2×	101	2.4k
Anne R. Meibohm United States	17	2.1k 1.6×	1.9k 2.1×	555 1.2×	295 0.8×	37 0.1×	27	2.9k

Countries citing papers authored by Gildon Beall

Since Specialization

Citations

This map shows the geographic impact of Gildon Beall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gildon Beall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gildon Beall more than expected).

Fields of papers citing papers by Gildon Beall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gildon Beall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gildon Beall. The network helps show where Gildon Beall may publish in the future.

Co-authorship network of co-authors of Gildon Beall

This figure shows the co-authorship network connecting the top 25 collaborators of Gildon Beall. A scholar is included among the top collaborators of Gildon Beall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gildon Beall. Gildon Beall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Walmsley, Sharon, Barry Bernstein, Martin King, et al.. (2002). Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection. New England Journal of Medicine. 346(26). 2039–2046. 518 indexed citations breakdown →

2.

Schooley, Robert T., Peter Ruane, Robert A. Myers, et al.. (2002). Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study. AIDS. 16(9). 1257–1263. 217 indexed citations

3.

Sorvillo, Frank, et al.. (2001). Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: Association with hospital exposure. American Journal of Infection Control. 29(2). 79–84. 15 indexed citations

4.

Haubrich, Richard, Judith S. Currier, Donald N. Forthal, et al.. (2001). A Randomized Study of the Utility of Human Immunodeficiency Virus RNA Measurement for the Management of Antiretroviral Therapy. Clinical Infectious Diseases. 33(7). 1060–1068. 23 indexed citations

5.

Javanbakht, Marjan, Atam B. Singh, Norman A. Mazer, et al.. (2000). Pharmacokinetics of a Novel Testosterone Matrix Transdermal System in Healthy, Premenopausal Women and Women Infected with the Human Immunodeficiency Virus¹. The Journal of Clinical Endocrinology & Metabolism. 85(7). 2395–2401. 23 indexed citations

6.

Wohl, Amy Rock, Denise F. Johnson, Wilbert Jordan, et al.. (2000). High-Risk Behaviors During Incarceration in African-American Men Treated for HIV at Three Los Angeles Public Medical Centers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(4). 386–392. 59 indexed citations

7.

Wohl, Amy Rock, Denise F. Johnson, Wilbert Jordan, et al.. (2000). High-Risk Behaviors During Incarceration in African-American Men Treated for HIV at Three Los Angeles Public Medical Centers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(4). 386–392. 34 indexed citations

8.

Pollard, Richard B., Dolores M. Peterson, David J. Hardy, et al.. (1999). Safety and Antiretroviral Effects of Combined Didanosine and Stavudine Therapy in HIV-Infected Individuals With CD4 Counts of 200 to 500 cells/mm3. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 22(1). 39–39. 23 indexed citations

9.

Sorvillo, Frank, Gildon Beall, Paul Turner, et al.. (1998). Seasonality and factors associated with cryptosporidiosis among individuals with HIV infection. Epidemiology and Infection. 121(1). 197–204. 32 indexed citations

10.

Beall, Gildon, et al.. (1997). DRUG REACTIONS AND DESENSITIZATION IN AIDS. Immunology and Allergy Clinics of North America. 17(2). 319–338. 7 indexed citations

11.

Sorvillo, Frank, et al.. (1997). Incidence and factors associated with extrapulmonary cryptococcosis among persons with HIV infection in Los Angeles County. AIDS. 11(5). 673–679. 30 indexed citations

12.

Beall, Gildon, et al.. (1995). Prevention of Recurrent Herpes Simplex Virus (HSV) Infections in HIV-infected Persons. Aids Patient Care. 9(5). 252–255. 3 indexed citations

13.

Grosvenor, Mary B., et al.. (1995). Dietary Intake and Counseling, Weight Maintenance, and the Course of HIV Infection. Journal of the American Dietetic Association. 95(4). 428–435. 69 indexed citations

14.

Beall, Gildon, et al.. (1994). Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients. Journal of Allergy and Clinical Immunology. 93(6). 1001–1005. 78 indexed citations

15.

Chlebowski, R. T., et al.. (1994). Long-term effects of early nutritional support with new enterotropic peptide-based formula vs. standard enteral formula in HIV-infected patients: randomized prospective trial.. PubMed. 9(6). 507–12. 53 indexed citations

16.

Zuraw, Bruce L., et al.. (1993). Immunoadsorption in Acquired Angioedema: A Therapeutic Misadventure. Clinical Immunology and Immunopathology. 66(2). 181–183. 4 indexed citations

17.

Kahn, James O., Stephen W. Lagakos, Douglas D. Richman, et al.. (1992). A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection. New England Journal of Medicine. 327(9). 581–587. 257 indexed citations

18.

Beall, Gildon, et al.. (1991). HIV-seropositive thrombocytopenia. AIDS. 5(11). 1351–1356. 9 indexed citations

19.

Beall, Gildon, Fatima Morales, David T. Imagawa, et al.. (1990). A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients. AIDS. 4(7). 679–682. 3 indexed citations

20.

Beall, Gildon, et al.. (1977). Perspectives on the Availability and Utilization of Foreign-Source Informational Materials in Gerontology. The Gerontologist. 17(6). 537–544. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact